Dupilumab for atopic dermatitis linked to lower antibody levels after COVID-19 infection

Mount Sinai Study Finds Long-Term Eczema Treatment Benefits Patients With Delayed Response

Mount Sinai Dermatologists Show Promising Results Using Combination Therapy for Vitiligo Patients

Mount Sinai Experts Author Landmark ‘Seminar’ on Atopic Dermatitis (Eczema) in The Lancet

‘Follow the science and follow your gut’ to make a change in medicine

Doctor Says Possible Solution for Alopecia in Children Could Be a Game-changer

Emma Guttman-Yassky, MD, PhD, Receives High Honor at European Academy of Allergy and Clinical Immunology

NIH awards Mount Sinai $6.6 million to research dupilumab as pediatric alopecia treatment

Mount Sinai Awarded $6.6 Million From National Institutes of Health to Investigate Treatment for Alopecia Areata in Children

Alopecia Areata and its Connections With Atopic Dermatitis

Clinique Partners with Icahn School of Medicine at Mount Sinai to Establish the Mount Sinai-Clinique Healthy Skin Dermatology Center

Mount Sinai Dermatology Experts Present Three Late-Breaking Research Papers at European Academy of Dermatology and Venereology Congress 2023